相关实验视频

Updated: Jan 9, 2026

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

含PA28γ的瘤衍生的外体促进T细胞功能障碍在头部和部状细胞癌

Ying Wang¹, Shiyu Zhang¹, Yang Yang²

¹State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Research Unit of Oral Carcinogenesis and Management & Chinese Academy of Medical Sciences, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.

Cellular & molecular immunology

|December 7, 2025

概括

癌细胞释放含有PA28γ的外体,这会损害T细胞功能,并促进头角状细胞癌 (HNSCC) 的瘤生长. 这种外体PA28γ通路突出了癌症免疫治疗的新目标.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
细胞生物学细胞生物学

背景情况:

外基因组在癌症中调解细胞间的通信.
癌症中PA28γ的升高调节,但其在瘤微环境中的作用尚不清楚.
头部和部状细胞癌 (HNSCC) 的进展涉及复杂的细胞相互作用.

研究的目的:

研究PA28γ在HNSCC外体中的作用及其对T细胞的影响.
阐明外体PA28γ影响T细胞功能和瘤进展的机制.
评估PA28γ作为HNSCC中的潜在生物标志物和治疗标.

主要方法:

在HNSCC衍生的外体体中分析PA28γ负载.
在体外研究T细胞内部化外体PA28γ和功能测试.
在体内研究使用PA28γ淘汰赛小鼠和正管移植模型.
质量细胞计 (CyTOF) 用于T细胞透分析.
对PA28γ表达的相关性分析与HNSCC队列中的临床数据.

主要成果:

PA28γ是由HNSCC细胞在外体内分泌,并由T细胞内化.
外体PA28γ减弱T细胞的细胞毒性,并增加CD25和LAG-3的表达,诱导T细胞耗尽.
PA28γ Knockdown 减少了耗尽的T细胞的透,并改善了瘤对免疫检查点治疗的反应.
PA28γ降解BCLAF1,调解其对T细胞的影响.
高PA28γ表达与增加的CD25+和LAG-3+T细胞相关,并预测HNSCC患者的预后不佳.

结论:

外体PA28γ通过PA28γ/BCLAF1/CD25&LAG-3通路诱导T细胞耗尽,促进HNSCC的进展.
在HNSCC微环境中,PA28γ代表了瘤-T细胞相互作用的新机制.
向外体PA28γ可能为HNSCC提供新的治疗策略.

关键词:

这就是BCLAF1的原因.CD25 CD25 CD25 CD25 CD25 CD25 CD25 CD25 CD25 CD25 CD25 CD25 外基因组是外基因组的组成部分.在HNSCC中,我们可以看到.免疫抑制是一种免疫抑制.现场行动组-3 在PA28γγ中.在T细胞,T细胞.

更多相关视频

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Receptor Downregulation in MVBs

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...